Clinical trials
Recruiting Choroidal Neovascularization trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 1 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 6 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| EyeBiotech Ltd. | 2 |
| Hospital Authority, Hong Kong | 1 |
| Institut National de la Santé Et de la Recherche Médicale, France | 1 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 1 |
| Tan Tock Seng Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Choroidal Neovascularization | 6 |
| Macular Degeneration | 5 |
| Wet Macular Degeneration | 2 |
| Central Serous Chorioretinopathy | 1 |
| Diabetic Retinopathy | 1 |
| Hyperaldosteronism | 1 |
| Macular Edema | 1 |
| Retinal Vein Occlusion | 1 |
Trials
Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.